187 related articles for article (PubMed ID: 31293592)
21. Engagement of CD83 on B cells modulates B cell function in vivo.
Kretschmer B; Lüthje K; Schneider S; Fleischer B; Breloer M
J Immunol; 2009 Mar; 182(5):2827-34. PubMed ID: 19234177
[TBL] [Abstract][Full Text] [Related]
22. CD83 expression is essential for Treg cell differentiation and stability.
Doebbeler M; Koenig C; Krzyzak L; Seitz C; Wild A; Ulas T; Baßler K; Kopelyanskiy D; Butterhof A; Kuhnt C; Kreiser S; Stich L; Zinser E; Knippertz I; Wirtz S; Riegel C; Hoffmann P; Edinger M; Nitschke L; Winkler T; Schultze JL; Steinkasserer A; Lechmann M
JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875316
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.
Seldon TA; Pryor R; Palkova A; Jones ML; Verma ND; Findova M; Braet K; Sheng Y; Fan Y; Zhou EY; Marks JD; Munro T; Mahler SM; Barnard RT; Fromm PD; Silveira PA; Elgundi Z; Ju X; Clark GJ; Bradstock KF; Munster DJ; Hart DN
Leukemia; 2016 Mar; 30(3):692-700. PubMed ID: 26286117
[TBL] [Abstract][Full Text] [Related]
24. Enhanced activation of CD83-positive T cells.
Wolenski M; Cramer SO; Ehrlich S; Steeg C; Fleischer B; von Bonin A
Scand J Immunol; 2003 Sep; 58(3):306-11. PubMed ID: 12950676
[TBL] [Abstract][Full Text] [Related]
25. CD83 on murine APC does not function as a costimulatory receptor for T cells.
Kretschmer B; Lüthje K; Ehrlich S; Osterloh A; Piedavent M; Fleischer B; Breloer M
Immunol Lett; 2008 Oct; 120(1-2):87-95. PubMed ID: 18675848
[TBL] [Abstract][Full Text] [Related]
26. Failed efficacy of soluble human CD83-Ig in allogeneic mixed lymphocyte reactions and experimental autoimmune encephalomyelitis: implications for a lack of therapeutic potential.
Pashine A; Göpfert U; Chen J; Hoffmann E; Dietrich PS; Peng SL
Immunol Lett; 2008 Jan; 115(1):9-15. PubMed ID: 18079004
[TBL] [Abstract][Full Text] [Related]
27. CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells.
Kretschmer B; Lüthje K; Guse AH; Ehrlich S; Koch-Nolte F; Haag F; Fleischer B; Breloer M
PLoS One; 2007 Aug; 2(8):e755. PubMed ID: 17710154
[TBL] [Abstract][Full Text] [Related]
28. Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner.
Royzman D; Andreev D; Stich L; Rauh M; Bäuerle T; Ellmann S; Boon L; Kindermann M; Peckert K; Bozec A; Schett G; Steinkasserer A; Zinser E
Front Immunol; 2019; 10():633. PubMed ID: 31001257
[TBL] [Abstract][Full Text] [Related]
29. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
30. CD83 regulates lymphocyte maturation, activation and homeostasis.
Breloer M; Fleischer B
Trends Immunol; 2008 Apr; 29(4):186-94. PubMed ID: 18329338
[TBL] [Abstract][Full Text] [Related]
31. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.
Lechmann M; Krooshoop DJ; Dudziak D; Kremmer E; Kuhnt C; Figdor CG; Schuler G; Steinkasserer A
J Exp Med; 2001 Dec; 194(12):1813-21. PubMed ID: 11748282
[TBL] [Abstract][Full Text] [Related]
32. Continuous expression of CD83 on activated human CD4⁺ T cells is correlated with their differentiation into induced regulatory T cells.
Chen L; Guan S; Zhou Q; Sheng S; Zhong F; Wang Q
Mol Med Rep; 2015 Sep; 12(3):3309-3314. PubMed ID: 25997495
[TBL] [Abstract][Full Text] [Related]
33. Multiplex and functional detection of antigen-specific human T cells by ITRA--indirect T cell recognition assay.
Tong L; Schuhmacher C; Assenmacher M; Zänker K; Jähn P
J Immunol Methods; 2014 Feb; 404():13-23. PubMed ID: 24333463
[TBL] [Abstract][Full Text] [Related]
34. CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.
Li Z; Ju X; Silveira PA; Abadir E; Hsu WH; Hart DNJ; Clark GJ
Front Immunol; 2019; 10():1312. PubMed ID: 31231400
[TBL] [Abstract][Full Text] [Related]
35. The CD83 Molecule - An Important Immune Checkpoint.
Grosche L; Knippertz I; König C; Royzman D; Wild AB; Zinser E; Sticht H; Muller YA; Steinkasserer A; Lechmann M
Front Immunol; 2020; 11():721. PubMed ID: 32362900
[TBL] [Abstract][Full Text] [Related]
36. Cxcl17
Hernández-Ruiz M; Othy S; Herrera C; Nguyen HT; Arrevillaga-Boni G; Catalan-Dibene J; Cahalan MD; Zlotnik A
J Leukoc Biol; 2019 May; 105(5):1027-1039. PubMed ID: 30860634
[TBL] [Abstract][Full Text] [Related]
37. Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells.
Cramer SO; Trumpfheller C; Mehlhoop U; Moré S; Fleischer B; von Bonin A
Int Immunol; 2000 Sep; 12(9):1347-51. PubMed ID: 10967030
[TBL] [Abstract][Full Text] [Related]
38. CD83 expression regulates antibody production in response to influenza A virus infection.
Akauliya M; Gautam A; Maharjan S; Park BK; Kim J; Kwon HJ
Virol J; 2020 Dec; 17(1):194. PubMed ID: 33302987
[TBL] [Abstract][Full Text] [Related]
39. CD83 expression influences CD4+ T cell development in the thymus.
Fujimoto Y; Tu L; Miller AS; Bock C; Fujimoto M; Doyle C; Steeber DA; Tedder TF
Cell; 2002 Mar; 108(6):755-67. PubMed ID: 11955430
[TBL] [Abstract][Full Text] [Related]
40. Role of CD83 in the immunomodulation of dendritic cells.
Lechmann M; Zinser E; Golka A; Steinkasserer A
Int Arch Allergy Immunol; 2002 Oct; 129(2):113-8. PubMed ID: 12403928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
